The prevalence of glucose metabolism abnormalities in Greek women with polycystic ovary syndrome

Gynecological Endocrinology

Volumn 28, Issue 11, 2012, Pages 867-870

  Trakakis, Eftihios ^a   Basios, George ^a   Peppa, Melpomeni ^a   Simeonidis, George ^a   Labos, George ^a   Creatsa, Maria ^a   Misailidou, Maria ^a   Boutati, Eleni ^a   Vaggopoulos, Vassilios ^a   Panagopoulos, Perikles ^a   Dimitriades, George ^a   Kassanos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Insulin; Insulin resistance; Polycystic ovary syndrome

Indexed keywords

ADULT; AGE; ARTICLE; BODY MASS; DISEASE SEVERITY; DISORDERS OF CARBOHYDRATE METABOLISM; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE METABOLISM; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN SENSITIVITY; MAJOR CLINICAL STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; OVARY POLYCYSTIC DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; WAIST CIRCUMFERENCE;

ADOLESCENT; ADULT; DIABETES MELLITUS, TYPE 2; FEMALE; GLUCOSE; GLUCOSE TOLERANCE TEST; GREECE; HUMANS; INSULIN RESISTANCE; POLYCYSTIC OVARY SYNDROME; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84867511623     PISSN: 09513590     EISSN: 14730766     Source Type: Journal    
DOI: 10.3109/09513590.2012.683058     Document Type: Article

References (28)

1. Asunci; M, Calvo RM, San Mill JL, Sancho J, Avila S, Escobar-Morreale HF. A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain. J Clin Endocrinol Metab 2000;85:2434-2438.
2. Knochenhauer ES, Key TJ, Kahsar-Miller M, Waggoner W, Boots LR, Azziz R. Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: A prospective study. J Clin Endocrinol Metab 1998;83:3078-3082.
3. Teede HJ, Hutchison S, Zoungas S, Meyer C. Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 2006;30:45-53.
4. Book CB, Dunaif A. Selective insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 1999;84:3110-3116.
5. Dunaif A, Segal KR, Shelley DR, Green G, Dobrjansky A, Licholai T. Evidence for distinctive and intrinsic defects in insulin action in polycystic ovary syndrome. Diabetes 1992;41:1257-1266.
6. Ciaraldi TP, el-Roeiy A, Madar Z, Reichart D, Olefsky JM, Yen SS. Cellular mechanisms of insulin resistance in polycystic ovarian syndrome. J Clin Endocrinol Metab 1992;75:577-583.
7. Dunaif A. Insulin resistance and the polycystic ovary syndrome: Mechanism and implications for pathogenesis. Endocr Rev 1997;18: 774-800.
8. Dunaif A, Wu X, Lee A, Diamanti-Kandarakis E. Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). Am J Physiol Endocrinol Metab 2001;281:E392-E399.
9. Norman RJ, Masters L, Milner CR, Wang JX, Davies MJ. Relative risk of conversion from normoglycaemia to impaired glucose tolerance or non-insulin dependent diabetes mellitus in polycystic ovarian syndrome. Hum Reprod 2001;16:1995-1998.
10. Dabadghao P, Roberts BJ, Wang J, Davies MJ, Norman RJ. Glucose tolerance abnormalities in Australian women with polycystic ovary syndrome. Med J Aust 2007;187:328-331.
11. Weerakiet S, Srisombut C, Bunnag P, Sangtong S, Chuangsoongnoen N, Rojanasakul A. Prevalence of type 2 diabetes mellitus and impaired glucose tolerance in Asian women with polycystic ovary syndrome. Int J Gynaecol Obstet 2001;75:177-184.
12. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab 1999;84: 165-169.
13. Ehrmann DA, Barnes RB, Rosenfield RL, Cavaghan MK, Imperial J. Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome. Diabetes Care 1999;22: 141-146.
14. Gambineri A, Pelusi C, Manicardi E, Vicennati V, Cacciari M, Morselli-Labate AM, Pagotto U, Pasquali R. Glucose intolerance in a large cohort of mediterranean women with polycystic ovary syndrome: Phenotype and associated factors. Diabetes 2004;53:2353-2358.
15. Moran LJ, Misso ML, Wild RA, Norman RJ. Impaired glucose tolerance, type 2 diabetes and metabolic syndrome in polycystic ovary syndrome: A systematic review and meta-analysis. Hum Reprod Update 2010;16:347-363.
16. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
17. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: Comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
18. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome. Fertil Steril 2004;81:19-25.
19. Report of the expert committee on the diagnosis and classification of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus (1997). Diabetes Care 1997;20: 1183-1197.
20. Panagiotakos DB, Pitsavos C, Skoumas Y, Lentzas Y, Stefanadis C. Five-year incidence of type 2 diabetes mellitus among cardiovascular disease-free Greek adults: Findings from the ATTICA study. Vasc Health Risk Manag 2008;4:691-698.
21. Tentolouris N, Andrianakos A, Karanikolas G, Karamitsos D, Trontzas P, Krachtis P, Christoyannis F, et al. Prevalence of diabetes mellitus and obesity in the general adult population of Greece: A door-to-door epidemiological study. Diabet Med 2009;26:451-452.
22. Espin-Gez JJ, Corcoy R, Calaf J. Prevalence and predictors of abnormal glucose metabolism in Mediterranean women with polycystic ovary syndrome. Gynecol Endocrinol 2009;25:199-204.
23. Chandrika N, Wijeyaratne A, Balen H, Barth J, Belchetz P. Clinical manifestations and insulin resistance (IR) in polycystic ovary syndrome (PCOS) among South Asians and Caucasians: Is there a difference?. Clin Endocrinol (Oxf) 2002;57:343-350.
24. Abate N, Chandalia M. Ethnicity and type 2 diabetes: Focus on Asian Indians. J Diabetes Complicat 2001;15:320-327.
25. Chen X, Yang D, Li L, Feng S, Wang L. Abnormal glucose tolerance in Chinese women with polycystic ovary syndrome. Hum Reprod 2006;21:2027-2032.
26. Katz A, Nambi SS, Mather K, Baron AD, Follmann DA, Sullivan G, Quon MJ. Quantitative insulin sensitivity check index: A simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85:2402-2410.
27. Katsuki A, Sumida Y, Gabazza EC, Murashima S, Furuta M, Araki-Sasaki R, Hori Y, et al. Homeostasis model assessment is a reliable indicator of insulin resistance during follow-up of patients with type 2 diabetes. Diabetes Care 2001;24:362-365.
28. Salley KE, Wickham EP, Cheang KI, Essah PA, Karjane NW, Nestler JE. POSITION STATEMENT: glucose intolerance in polycystic ovary syndrome-a position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92:4546-4556.